Cargando…

Intermuscular adipose tissue in patients with systemic lupus erythematosus

OBJECTIVE: Patients with SLE frequently have debilitating fatigue and reduced physical activity. Intermuscular adipose tissue (IMAT) accumulation is associated with reduced physical exercise capacity. We hypothesised that IMAT is increased in patients with SLE and associated with increased fatigue,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gamboa, Jorge Luis, Carranza-León, Daniel, Crescenzi, Rachelle, Pridmore, Michael, Peng, Dungeng, Marton, Adriana, Oeser, Annette, Chung, Cecilia P, Titze, Jens, Stein, Charles Michael, Ormseth, Michelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684966/
https://www.ncbi.nlm.nih.gov/pubmed/36414333
http://dx.doi.org/10.1136/lupus-2022-000756
_version_ 1784835401788162048
author Gamboa, Jorge Luis
Carranza-León, Daniel
Crescenzi, Rachelle
Pridmore, Michael
Peng, Dungeng
Marton, Adriana
Oeser, Annette
Chung, Cecilia P
Titze, Jens
Stein, Charles Michael
Ormseth, Michelle
author_facet Gamboa, Jorge Luis
Carranza-León, Daniel
Crescenzi, Rachelle
Pridmore, Michael
Peng, Dungeng
Marton, Adriana
Oeser, Annette
Chung, Cecilia P
Titze, Jens
Stein, Charles Michael
Ormseth, Michelle
author_sort Gamboa, Jorge Luis
collection PubMed
description OBJECTIVE: Patients with SLE frequently have debilitating fatigue and reduced physical activity. Intermuscular adipose tissue (IMAT) accumulation is associated with reduced physical exercise capacity. We hypothesised that IMAT is increased in patients with SLE and associated with increased fatigue, reduced physical activity and increased inflammation. METHODS: In a cross-sectional study, 23 patients with SLE and 28 control participants were evaluated. IMAT was measured in the calf muscles using sequential T(1)-weighted MRI. Patient-reported physical activity and fatigue were measured and a multiplex proteomic assay was used to measure markers and mediators of inflammation. RESULTS: IMAT accumulation (percentage of IMAT area to muscle area) was significantly higher in SLE versus control participants (7.92%, 4.51%–13.39% vs 2.65%, 1.15%–4.61%, median, IQR, p<0.001) and remained significant after adjustment for age, sex, race and body mass index (p<0.001). In patients with SLE, IMAT accumulation did not differ significantly among corticosteroid users and non-users (p=0.48). In the study cohort (patients and controls), IMAT was positively correlated with self-reported fatigue score (rho=0.52, p<0.001) and inversely correlated with self-reported walking distance (rho=−0.60, p<0.001). Several markers of inflammation were associated with IMAT accumulation in patients with SLE, and gene ontology analysis showed significant enrichment for pathways associated with macrophage migration and activation in relation to IMAT. CONCLUSION: Patients with SLE have greater IMAT accumulation than controls in the calf muscles. Increased IMAT is associated with greater fatigue and lower physical activity. Future studies should evaluate the effectiveness of interventions that improve muscle quality to alleviate fatigue in patients with SLE.
format Online
Article
Text
id pubmed-9684966
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-96849662022-11-25 Intermuscular adipose tissue in patients with systemic lupus erythematosus Gamboa, Jorge Luis Carranza-León, Daniel Crescenzi, Rachelle Pridmore, Michael Peng, Dungeng Marton, Adriana Oeser, Annette Chung, Cecilia P Titze, Jens Stein, Charles Michael Ormseth, Michelle Lupus Sci Med Immunology and Inflammation OBJECTIVE: Patients with SLE frequently have debilitating fatigue and reduced physical activity. Intermuscular adipose tissue (IMAT) accumulation is associated with reduced physical exercise capacity. We hypothesised that IMAT is increased in patients with SLE and associated with increased fatigue, reduced physical activity and increased inflammation. METHODS: In a cross-sectional study, 23 patients with SLE and 28 control participants were evaluated. IMAT was measured in the calf muscles using sequential T(1)-weighted MRI. Patient-reported physical activity and fatigue were measured and a multiplex proteomic assay was used to measure markers and mediators of inflammation. RESULTS: IMAT accumulation (percentage of IMAT area to muscle area) was significantly higher in SLE versus control participants (7.92%, 4.51%–13.39% vs 2.65%, 1.15%–4.61%, median, IQR, p<0.001) and remained significant after adjustment for age, sex, race and body mass index (p<0.001). In patients with SLE, IMAT accumulation did not differ significantly among corticosteroid users and non-users (p=0.48). In the study cohort (patients and controls), IMAT was positively correlated with self-reported fatigue score (rho=0.52, p<0.001) and inversely correlated with self-reported walking distance (rho=−0.60, p<0.001). Several markers of inflammation were associated with IMAT accumulation in patients with SLE, and gene ontology analysis showed significant enrichment for pathways associated with macrophage migration and activation in relation to IMAT. CONCLUSION: Patients with SLE have greater IMAT accumulation than controls in the calf muscles. Increased IMAT is associated with greater fatigue and lower physical activity. Future studies should evaluate the effectiveness of interventions that improve muscle quality to alleviate fatigue in patients with SLE. BMJ Publishing Group 2022-11-22 /pmc/articles/PMC9684966/ /pubmed/36414333 http://dx.doi.org/10.1136/lupus-2022-000756 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Immunology and Inflammation
Gamboa, Jorge Luis
Carranza-León, Daniel
Crescenzi, Rachelle
Pridmore, Michael
Peng, Dungeng
Marton, Adriana
Oeser, Annette
Chung, Cecilia P
Titze, Jens
Stein, Charles Michael
Ormseth, Michelle
Intermuscular adipose tissue in patients with systemic lupus erythematosus
title Intermuscular adipose tissue in patients with systemic lupus erythematosus
title_full Intermuscular adipose tissue in patients with systemic lupus erythematosus
title_fullStr Intermuscular adipose tissue in patients with systemic lupus erythematosus
title_full_unstemmed Intermuscular adipose tissue in patients with systemic lupus erythematosus
title_short Intermuscular adipose tissue in patients with systemic lupus erythematosus
title_sort intermuscular adipose tissue in patients with systemic lupus erythematosus
topic Immunology and Inflammation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684966/
https://www.ncbi.nlm.nih.gov/pubmed/36414333
http://dx.doi.org/10.1136/lupus-2022-000756
work_keys_str_mv AT gamboajorgeluis intermuscularadiposetissueinpatientswithsystemiclupuserythematosus
AT carranzaleondaniel intermuscularadiposetissueinpatientswithsystemiclupuserythematosus
AT crescenzirachelle intermuscularadiposetissueinpatientswithsystemiclupuserythematosus
AT pridmoremichael intermuscularadiposetissueinpatientswithsystemiclupuserythematosus
AT pengdungeng intermuscularadiposetissueinpatientswithsystemiclupuserythematosus
AT martonadriana intermuscularadiposetissueinpatientswithsystemiclupuserythematosus
AT oeserannette intermuscularadiposetissueinpatientswithsystemiclupuserythematosus
AT chungceciliap intermuscularadiposetissueinpatientswithsystemiclupuserythematosus
AT titzejens intermuscularadiposetissueinpatientswithsystemiclupuserythematosus
AT steincharlesmichael intermuscularadiposetissueinpatientswithsystemiclupuserythematosus
AT ormsethmichelle intermuscularadiposetissueinpatientswithsystemiclupuserythematosus